Assertio Holdings Inc 's ability to collect accounts receivable sequentially worsen to 1.06, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Assertio Holdings Inc 's Accounts Receivable average collection period in the Mar 31 2026 quarter, has increased to 344 days, from 299 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 509 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 2050 to 3155.

What is Receivable Turnover Ratio?
What is Assertio Holdings Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ASRT Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	-7.19 %	121.93 %	214.41 %	53.06 %	55.58 %
Y / Y Revenue Change	-62.5 %	-57.92 %	69.36 %	-6.12 %	-18.37 %
Receivable Turnover Ratio (TTM)	1.06	1.22	1.7	2.07	2.32
ASRT's Total Ranking	# 3155	# 2050	# 3132	# 2938	# 2927
Accounts Receivable average collection period days	343	299	214	176	157
Seq. Receivable Change	-48.77 %	-15 %	131.31 %	-7.85 %	22.49 %
Seq. Revenue Change	-26.66 %	-72.62 %	69.25 %	10.32 %	-17.7 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 169
Healthcare Sector	# 510
Overall Market	# 3155

Receivable Turnover Ratio Statistics
High	Average	Low
33.35	8.16	1.06
(Dec 31 2012)		(Mar 31 2026)

ASRT Company Profile • Back to ASRT Efficiency Comparisons • Compare ASRT Receivables Turnover Ratio to its Competitors

Financial Statements
Assertio Holdings Inc 's Accounts Receivable	$ 62 Millions	Visit ASRT's Balance sheet
Assertio Holdings Inc 's Sales TTM	$ 102 Millions	Visit ASRT's Income Statement
Sources of ASRT's Revenues		Visit ASRT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ASRT's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ASRT's Growth Rates	ASRT's Roa	ASRT's Inventory Turnover Ratio	ASRT's Dividend Comparisons
ASRT's Profitability Ratios	ASRT's Roi	ASRT's Asset Turnover Ratio	ASRT's Dividend Growth
ASRT's Valuation Ratios	ASRT's Roe	ASRT's Financial Strength Ratios	ASRT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Cryo cell International Inc	4.56	$ 31.281 Millions	$ 6.857 Millions
Supernus Pharmaceuticals inc	4.56	$ 776.833 Millions	$ 170.518 Millions
Orthopediatrics Corp	4.53	$ 241.789 Millions	$ 53.335 Millions
Bioventus Inc	4.50	$ 575.558 Millions	$ 127.900 Millions
Gyre Therapeutics Inc	4.49	$ 117.049 Millions	$ 26.087 Millions
Omniab Inc	4.48	$ 28.939 Millions	$ 6.458 Millions
Neurocrine Biosciences Inc	4.47	$ 3,102.400 Millions	$ 694.650 Millions
Bristol myers Squibb Company	4.45	$ 48,482.000 Millions	$ 10,904.750 Millions
Lantheus Holdings Inc	4.41	$ 1,545.174 Millions	$ 350.565 Millions
Urogen Pharma Ltd	4.37	$ 139.526 Millions	$ 31.962 Millions
Eli Lilly And Company	4.35	$ 72,249.500 Millions	$ 16,616.700 Millions
Organon and Co	4.35	$ 6,175.000 Millions	$ 1,420.750 Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________	4.33	$ 20.577 Millions	$ 4.757 Millions
Absci Corp	4.32	$ 1.836 Millions	$ 0.425 Millions
Bridgebio Pharma Inc	4.31	$ 579.958 Millions	$ 134.514 Millions
Alkermes Plc	4.31	$ 1,562.300 Millions	$ 362.739 Millions
Regenxbio Inc	4.29	$ 87.822 Millions	$ 20.491 Millions
Glaukos Corp	4.27	$ 437.645 Millions	$ 102.492 Millions
Arbutus Biopharma Corp	4.24	$ 191.445 Millions	$ 45.168 Millions
Pro dex Inc	4.23	$ 74.636 Millions	$ 17.643 Millions
Biocorrx Inc	4.23	$ 0.877 Millions	$ 0.207 Millions
Sera Prognostics Inc	4.22	$ 0.057 Millions	$ 0.014 Millions
Fulgent Genetics Inc	4.22	$ 319.019 Millions	$ 75.604 Millions
Vanda Pharmaceuticals Inc	4.21	$ 217.782 Millions	$ 51.748 Millions
Revvity Inc	4.18	$ 2,902.407 Millions	$ 694.362 Millions
Vivosim Labs Inc	4.16	$ 0.131 Millions	$ 0.032 Millions
Amgen Inc	4.15	$ 37,220.000 Millions	$ 8,974.750 Millions
Vericel Corporation	4.15	$ 292.086 Millions	$ 70.433 Millions
Ptc Therapeutics inc	4.13	$ 827.110 Millions	$ 200.187 Millions
Apyx Medical Corp	4.11	$ 55.304 Millions	$ 13.443 Millions

Date modified: 2026-10-05T11:03:40+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.